Candel Therapeutics (CADL) Total Debt: 2020-2022

Historic Total Debt for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $20.2 million.

  • Candel Therapeutics' Total Debt rose 1.58% to $20.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $20.4 million, marking a year-over-year increase of 1.58%. This contributed to the annual value of $20.2 million for FY2022, which is 3507.50% up from last year.
  • As of FY2022, Candel Therapeutics' Total Debt stood at $20.2 million, which was up 3,507.50% from $560,000 recorded in FY2021.
  • Candel Therapeutics' Total Debt's 5-year high stood at $20.2 million during FY2022, with a 5-year trough of $463,000 in FY2020.
  • Moreover, its 3-year median value for Total Debt was $560,000 (2021), whereas its average is $7.1 million.
  • Data for Candel Therapeutics' Total Debt shows a peak YoY spiked of 3,507.50% (in 2022) over the last 5 years.
  • Over the past 3 years, Candel Therapeutics' Total Debt (Yearly) stood at $463,000 in 2020, then increased by 20.95% to $560,000 in 2021, then surged by 3,507.50% to $20.2 million in 2022.